**THE SMITH-MAGENIS SYNDROME (SMS) FOUNDATION UK CIO** Registered UK Charity No: 1186647 

## **ACCOUNTS** 

## **30[TH] JUNE 2020** 

________________________________________ 

Smith-Magenis Syndrome (SMS) Foundation UK BCM Smith-Magenis Syndrome Foundation London WC1N 3XX 

________________________________________ 



## **THE SMITH-MAGENIS SYNDROME (SMS) FOUNDATION UK CIO** 

## **Contents of the Financial Statements** 

## **For the year ended 30[th ] June 2020** 

||Page|
|---|---|
|Annual Report of the Trustees|3|
|Independent Examiner’s Report|7|
|The Smith-Magenis Syndrome (SMS) Foundation UK CIO, 1186647|9|
|Receipts and Payments Account (General Purpose Fund)||
|Statement of Assets and Liabilities|10|
|Notes to the Accounts|11|



Page 2 



## **THE SMITH-MAGENIS SYNDROME (SMS) FOUNDATION UK CIO** 

## **Annual Report of the Trustees for the year ended 30[th] June 2020** 

The Trustees have pleasure in presenting their report together with the financial statements and the independent examiner’s report for the year ended 30 June 2020. 

**The Smith-Magenis Syndrome (SMS) Foundation UK CIO** , 1186647, is a Charitable Incorporated Organisation. It is governed by its foundation constitution which was adopted on 16 November 2019. The Smith-Magenis Syndrome (SMS) Foundation UK CIO became registered with the Charities Commission on 28 November 2019. 

At an Extra-ordinary General Meeting (EGM) of the Smith-Magenis Syndrome (SMS) Foundation UK, charity no. 1072573 held on 16 November 2019 the membership voted in favour of transitioning the organisation from an unincorporated registered charity to a Charitable Incorporated Organisation (CIO). This vote held to the establishment and registration of the Smith-Magenis Syndrome (SMS) Foundation UK CIO. The transitioning period has extended beyond 30 June 2020. 

## **Reference & Administrative Information** 

|**Charity Name:**|**Charity Registration:**|
|---|---|
|The Smith-Magenis Syndrome (SMS) Foundation UK|UK Registered Charity No 1072573<br>Registered Scottish CharitySC044841|
|The Smith-Magenis Syndrome(SMS)Foundation UK CIO|UK Registered CharityNo 1186647|



## **Registered Address:** 

Smith-Magenis Syndrome (SMS) Foundation UK, BCM Smith-Magenis Syndrome Foundation, London, WC1N 3XX 

## **Operating Address:** 

Smith-Magenis Syndrome (SMS) Foundation UK, 12 Bankton Brae, Livingston, West Lothian, EH54 9LA 

## **Current Trustees:** 

The Charity is administered as a single operating entity, “The Foundation”, by a management committee, comprising: 

|**Name**|**Elected**|**Resigned**|
|---|---|---|
|Hazel Wotherspoon(Chairperson)|16/11/2019||
|Nick Hunt|16/11/2019||
|Nigel Over|16/11/2019|31/03/2020|
|Leeann Stevenson|16/11/2019|31/03/2020|
|Emma Riddell|16/11/2019||
|Mick Pearson|16/11/2019||



The Trustees also comprise the management committee of the Smith-Magenis Syndrome (SMS) Foundation UK, UK Charity No 1072573 and Scottish Charity SC044841. 

Page 3 



## **Structure Governance & Management** 

## **Constitution:** 

**The Smith-Magenis Syndrome (SMS) Foundation UK CIO** , 1186647, is a Charitable Incorporated Organisation. It is governed by its foundation constitution which was adopted on 16 November 2019. The Smith-Magenis Syndrome (SMS) Foundation UK CIO became registered with the Charities Commission on 28 November 2019. 

## **Appointment of Trustees:** 

Trustees are elected at the Annual General Meeting to serve for terms of three years. Retiring trustees are eligible to stand for re-election. 

The constitution for **The Smith-Magenis Syndrome (SMS) Foundation UK CIO** , 1186647, states that there must be no less than three trustees. A minimum of one-third of the trustees are to have a direct family connection to Smith-Magenis syndrome. 

## **Management:** 

The Trustees are responsible for the strategic direction and governance of the charity, and for the delivery of charitable activities to meet the objectives. 

On 01 April 2020 a Senior Management Team was employed to run the day-to-day operations of the Smith-Magenis Syndrome (SMS) Foundation UK CIO. The Management team comprises: Chief Executive Officer: Nigel Over Information & Communications Manager: Leeann Stevenson Fundraising Manager: Helen Hargrave 

## **Objectives & Activities** 

## **Charitable Purposes:** 

The charities’ objects (“the objects”) are: 

1. To preserve and protect the health and promote the relief of persons affected by Smith-Magenis Syndrome and any associated condition, 

2. To advance the education of the medical profession and the general public on the subject of Smith-Magenis Syndrome and its implications for the family, 

3. To advance public education by promoting research into the management of Smith-Magenis Syndrome and to publish the useful results thereof and to support organisations promoting research into Smith-Magenis Syndrome. 

## **Achievements & Performance:** 

During the reporting period, the Foundation continued to deliver activities to meet the objects of the charities, and particularly: 

- the Foundation has 534 registered supporters and has identified 302 individuals in the UK who have a diagnosis of Smith-Magenis Syndrome, 

- actively raised the profile of the Foundation through fundraising and awareness campaigns, 

- promoted further collaboration in research into Smith-Magenis Syndrome, 

- improved the lives of people with Smith-Magenis Syndrome through the £500 maximum individual small grants scheme, 

- responded to Covid-19 with focussed information and support through community cohesion initiatives including: 

   - Syndrome emergency packs and Alert ID Cards, 

   - Videoconferencing community drop-in support sessions, 

Page 4 



   - In the home activities as a series of Bear Hug and Be Hugged themed events, 

   - Greater social media presence, website enhancements and regular newsletters, 

- Commenced the implementation of the business development strategy for the growth of the charity over the next 1, 3, 5 and 10 years, 

- Recruited the Senior Management Team to run the Foundation. 

## **Financial Review** 

The Trustees continued to make extensive efforts to raise funds and support for the Foundation throughout the year. £10,388 was raised this year through charitable donations and general fundraising activities as a result of the tireless efforts of our Trustees and supporters. Further income of £3,000 has come in the form of Trusts and Funds Grants towards the development of our Information / Support Service. This gives a combined income of £13,388 for the Foundation over the financial year. 

Significant expenditure in 2019-20 was made to support the transition of the Foundation to a staffed Charitable Incorporated Organisation. 

- £2,348 was spent in connection with Fundraising activities. Expense has been incurred for enhanced fundraising platform subscriptions, promotional materials including the mascot costume, merchandising items, and event entries. 

- £4,848 has been spent on the running of the Foundation with staff salaries accounting for £3,955 of this amount. 

- One grant to improve the life of a person with Smith-Magenis syndrome of £500 was provided towards the cost of a specialist tricycle. 

Money assets at the year end of 30 June 2020 was £5,692 for which £3,000 is restricted funding for the Information and Support Service. 

## **Reserves Policy** 

From 01 April 2020, the Foundation has moved to a staffed organisation necessitating the implementation of a reserves policy and strategy. It is the intention of the Foundation to seek to retain a minimum of twelve months of core operating expenditure as the basis of its cash reserves, excluding restricted funding for projects. However, in light of Covid-19 and the move to employing staff members, the Board’s position is that the Foundation should maintain six months of reserves as a reasonable position under current circumstances. Should unrestricted reserves drop to three months of core operating costs then contingency measures would be implemented to lower planned expenditure to sustain the charity for at least one year. 

## **Plans for Future Periods** 

During the next financial year, the Foundation intends to continue to deliver activities to meet the objects of the charity, with specific objectives to: 

Connecting Families 

- provide continuing Covd-19 community cohesion activities including videoconferencing and home orientated activities, 

- promote social gatherings and meetings to connect families together, 

- establish a regional support network for families, 

- organise the biennial conference for May 2021 

Page 5 



## Raising Awareness 

- continue to develop networks for mutual support with charities of a similar nature and establish applicable alliances, both in the United Kingdom and internationally, 

- to actively raise the profile of the Foundation through fundraising and awareness campaigns, 

- develop and produce education and information videos and guidelines to assist those supporting people with Smith-Magenis Syndrome, 

## Building Futures 

- provide an information and support services for families and professionals, 

- conclude research into sleep safety and security within Smith-Magenis Syndrome, 

- undertake a demographics study to establish a more definitive understanding of the prevalence and geographical location of Smith-Magenis syndrome in the UK, 

- develop a programme of continuing research, 

- commission research into behaviour improvement utilising vagus nerve stimulation, 

- improve the lives of people with Smith-Magenis Syndrome through the individual small grants scheme, 

## Sustainability 

- complete the transition to the Charitable Incorporated Organisation, 

- continue with the business development strategy for the growth of the charity over the coming years, 

- develop the organisational structure to deliver our strategic objectives effectively and efficiently. 

Approved by the trustees and signed on their behalf by: 


Hazel Wotherspoon – Chairperson 

Date: 12 January 2021 

THE SMITH-MAGENIS SYNDROME (SMS) FOUNDATION UK 

Page 6 



## **Independent Examiner’s Report to the Trustees of THE SMITH-MAGENIS SYNDROME (SMS) FOUNDATION UK CIO For the year ended 30 June 2020** 

## **Independent Examiner’s Report on the Accounts** 

Report to the trustees / members of: The Smith-Magenis Syndrome (SMS) Foundation UK CIO On accounts of the charity for: 28 November 2019 to 30 June 2020 Charity Registration: Registered UK Charity 1186647 Set out on pages: Pages 9 and 10 

## **Respective responsibilities of trustees and examiner** 

The charity's trustees are responsible for the preparation of the accounts in accordance with the terms of the Charities Act 2011, the Charities and Trustee Investment (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006. 

The charity’s trustees consider that an audit is not required for this year under section 144 of the Charities Act 2011 and that the audit requirement of Regulation 10(1) (d) of the Charities Accounts (Scotland) Regulations 2006 does not apply. 

It is my responsibility: 

- examine the accounts under section 145 of the Charities Act, 

- to follow the procedures laid down in the general Directions given by the Charity Commission (under section 145(5)(b) of the Charities Act), and 

- examine the accounts as required under section (44)(1) (c) of the Charities and Trustee Investment (Scotland) Act 2005 

- to state whether particular matters have come to my attention. 

## **Basis of independent examiner’s statement** 

My examination was carried out in accordance with general Directions given by the Charity Commission and with Regulation 11 of the Charities Accounts (Scotland) Regulations 2006. 

An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records.  It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a ‘true and fair’ view and the report is limited to those matters set out in the statement below. 

## **Independent examiner's statement** 

In connection with my examination, no matter has come to my attention: 

1. which gives me reasonable cause to believe that in, any material respect, the requirements: 

   - to keep accounting records in accordance with section 130 of the Charities Act 2011 and with section 44(1)(a) of the Charities and Trustee Investment (Scotland) Act 2005 and Regulation 4 of the Charities Accounts (Scotland) Regulations 2006; and 

Page 7 



- to prepare accounts which accord with the accounting records and comply with the accounting requirements of the Charities Act 2011 and Regulation 9 of the Charities Accounts (Scotland) Regulations 2006 

have not been met; or 

2. to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached. 

Signed: Date: 12 January 2021 

Name: Mark Middleton 

Relevant professional qualification(s) or body (if any): FCA 

Address: 1 Vicarage Lane, E15 4HF 

Page 8 



## **THE SMITH-MAGENIS SYNDROME (SMS) FOUNDATION UK CIO, 1186647** 

## **Accounts for the period 28[th] November 2019 to 30[th] June 2020** 

## **Statement of Receipts and Payments Account (General Purpose Fund)** 

## **Receipts and Payments Account: General Fund** 

|**Receipts**<br>Voluntary Sources<br>Donations and membership fees<br>Grants<br>Receipts from fundraising activities<br>Organised Event Income<br>**Total Receipts / Income**<br>**Payments**<br>Expenses for fundraising activities<br>Payments relating directly to<br>charitable activities<br>Events<br>Grants<br>Governance Costs<br>Trustee Expenses<br>**Total Expenditure / Payments**<br>Total Receipts<br>Total Payments<br>**Surplus / (Deficit) for the year**<br>Transfers between funds<br>**Surplus / (Deficit) for the year**|Note|£<br>£<br>**£**<br>£<br>Unrestricted<br>Funds<br>Restricted<br>Funds<br>**Total**<br>**2020**<br>Total<br>2019|
|---|---|---|
||8<br>1,702.76<br>-<br>**1,702.76**<br>-<br>4<br>-<br>3,000.00<br>**3,000.00**<br>-<br>8<br>8,684.86<br>-<br>**8,684.86**<br>-<br>9<br>-<br>-<br>**-**<br>-<br>10,387.62<br>3,000.00<br>**13,387.62**<br>**-**<br>8<br>2,347.60<br>-<br>**2,347.60**<br>-<br>4,5,7,11<br>4,803.01<br>-<br>**4,803.01**<br>-<br>9<br>-<br>-<br>**-**<br>-<br>10<br>500.00<br>-<br>**500.00**<br>-<br>13<br>-<br>**-**<br>-<br>6<br>45.24<br>-<br>**45.24**<br>-<br>7,695.85<br>-<br>**7,695.85**<br>**-**<br>10,387.62<br>3,000.00<br>**13,387.62**<br>-<br>7,695.85<br>-<br>**7,695.85**<br>-<br>2,691.77<br>3,000.00<br>**5,691.77**<br>**-**<br>12<br>-<br>-<br>**-**<br>-<br>2,691.77<br>3,000.00<br>**5,691.77**<br>**-**|1,702.76<br>-<br>**1,702.76**<br>-<br>-<br>3,000.00<br>**3,000.00**<br>-<br>8,684.86<br>-<br>**8,684.86**<br>-<br>-<br>-<br>**-**<br>-|
|||10,387.62<br>3,000.00<br>**13,387.62**<br>**-**|
|||7,695.85<br>-<br>**7,695.85**<br>**-**|
|||10,387.62<br>3,000.00<br>**13,387.62**<br>-<br>7,695.85<br>-<br>**7,695.85**<br>-|
|||2,691.77<br>3,000.00<br>**5,691.77**<br>**-**<br>-<br>-<br>**-**<br>-|
|||2,691.77<br>3,000.00<br>**5,691.77**<br>**-**|



The Notes on pages 11 and 12 form an integral part of these accounts. 

Page 9 



## **THE SMITH-MAGENIS SYNDROME (SMS) FOUNDATION UK** 

## **Statement of Balances on Assets and Liabilities as of 30[th] June 2020** 

|**Fund Reconciliation**<br>Cash at Bank & In Hand – Start of year<br>Surplus / (Deficit) for the year<br>**Cash at Bank & In Hand – end of year**|£<br>£<br>**£**<br>£<br>Unrestricted<br>Funds<br>Restricted<br>Funds<br>**Total**<br>**2020**<br>Total<br>2019|
|---|---|
||-<br>-<br>**-**<br>-<br>2,691.77<br>3,000.00<br>**5,691.77**<br>-|
||2,691.77<br>3,000.00<br>**5,691.77**<br>**-**|



|**Bank & Cash Balances**<br>**The Smith-Magenis Syndrome (SMS) Foundation UK CIO (1186647)**<br>CAF Bank Account (1186647, part of)<br>PayPal Account (1186647)<br>Cash in Hand|**5,125.66**<br>-<br>**566.11**<br>-<br>**-**<br>-|
|---|---|
||**5,691.75**<br>-|



|**Other Assets (Unrestricted Fund)**<br>There are no other assets<br>**Liabilities (Unrestricted Fund)**<br>No current unrestricted fund liabilities<br>**Liabilities (Restricted Fund)**<br>Information and Support Service|Total Value|**-**<br>-|
|---|---|---|
|||**-**<br>-|
|||**20/21 Due**<br>19/20 Paid|
||3,000.00|**3,000.00**<br>-|
||3,000.00|**3,000.00**<br>-|



The Notes on pages 11 and 12 form an integral part of these accounts. 

Approved by the Trustees and signed on their behalf by: 


Nigel Over 


Hazel Wotherspoon (Chairperson) 

Date: 12 January 2021 

Page 10 



**Notes to the Accounts – For the Year Ended 30 June 2020** 

## **1. Basis of Accounting** 

These accounts have been prepared on the Receipts & Payments basis in accordance with the Charities Act 2011, Charities & Trustee Investment (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006 (as amended). 

## **2. Nature and purpose of the funds** 

Unrestricted funds are those that may be used at the discretion of the trustees in furtherance of the objects of the charity. The trustees maintain a single unrestricted fund for the running of the charity. 

Restricted funds may only be used for specific purposes. Restrictions arise when specified by the donor or when funds are raised for specific purposes. During the year, the charity received no restricted funding. 

## **3. Related Party Transactions** 

The charity’s insurance policy includes Trustee Indemnity for all its trustees. No other remuneration was paid to the trustees or to any connected persons during the year. 

## **4. Grants Received** 

The following grants were received during 2019-2020: 

|**Trust or Fund**|**Value**|**Purpose**|**Period**<br>**Covered**|
|---|---|---|---|
|P F Foundation|£3,000|Information and Support Service|Jun-Dec 2020|



A pledge of £1,000 from the Baily Thomas Foundation Trust has been given. 

## **5. Administration** 

All costs associated with consumed stationery, newsletter printing, correspondence, website hosting fees, virtual office fees, and insurance premiums have been combined under this heading. 

## **Staff Employed** 

Number of staff employed: 3 (1.4 to 1.7 FTE) Period of employment: From 01 April 2020 Staff salaries including taxes and pensions: £3,955 

No member of staff has a salary above £60,000 p.a. 

## **6. Trustee Expenses** 

Trustees claimed expenses totalling £45 during the period for reimbursement of general travelling costs and subsistence relating to activities of the charity. 

Travel and subsistence costs related directly to other activities and services of the Foundation has been included within the costs for these items. 

Reimbursement of expenditure on direct purchases on behalf of the charity is recorded under Administration. 

No professional nor legal fees were incurred during 2019-20. 

Page 11 



## **7. Publications** 

The charity has moved to electronic publishing through the website and social media removing printing of newsletters and other materials, except for a limited number of members. 

No costs were incurred to support the production and distribution of the publications. 

## **8. Fundraising** 

Subscriptions to the Fundraising Regulator and one fundraising platform incurred a cost of £290. 

Fundraising includes all member led activities where contributions have been acquired or requested in respect to these activities. 

Fundraising also includes the text to donate campaigns run by the charity. 

General merchandising items cost £2,058 which includes £450 for the Foundation’s mascot. 

Donations are recorded as the basis of receiving of an altruistic gift either with a general charitable purpose or for the support of a project. 

The Foundation received one donation of £1,000 from Flynn Pharma Ltd. 

## **9. Events** 

No events have taken place in the reporting period that have incurred any costs nor generated any income. 

## **10. Grants** 

Grants to improve the life of persons with Smith-Magenis syndrome totalled £500 and included: 

- £500 towards the costs of a specialist tricycle 

## **11. Research** 

No research has been commissioned by The Smith-Magenis Syndrome (SMS) Foundation UK CIO (1186647) during this reporting period. 

## **12. Transfers between funds** 

No transfers are recorded as taking place between funds during the reporting period. 

As part of the transition to the Charitable Incorporated Organisation, the assets from The SmithMagenis Syndrome (SMS) Foundation UK (1072573 / SC044841) will be transferred to The SmithMagenis Syndrome (SMS) Foundation UK CIO (1186647). 

## **13. Governance Costs** 

No costs relating to the governance of The Smith-Magenis Syndrome (SMS) Foundation UK CIO have been incurred within the accounting period. 

Page 12 

